CAT and cancer: In cancer cells, CAT repression has been shown to be linked to hypermethylation of the CpG island in the gene promoter, to histone deacetylation, to the expression of miR-30b, and to the high level of c-abl, which can lead to catalase protein degradation via post-translational modifications [11].